Tobacco Cessation in Economically Disadvantaged Dominican Republic Communities: Who are the Ex-Users?

Ossip, Deborah J.; Quiñones, Zahíra; Díaz, Sergio; Thevenet-Morrison, Kelly; Fisher, Susan G.; Holderness, Heather; Cai, X.; McIntosh, Scott; Dozier, Ann; Chin, Nancy P.; Weber, Emily A.; Sánchez, José Javier; Bautista, A. P.; Almonte, Hector

doi:10.1017/jsc.2015.3

Cited by 3 publications

(5 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The recent meeting of the Working Group of the European-Latin American Respiratory Diseases Society held in Madrid showed that Latin America is making progress in smoking control [209], but that it is still necessary to increase the strictness of antismoking laws, increase taxes on cigarettes and develop alternative packaging plans. In Latin America, the results of smoking control programs have been reported in recent years [210][211][212][213][214][215][216][217][218][219][220][221][222][223][224][225][226], with excellent results obtained in Uruguay, Brazil, Chile and Panama through actions, such as the prohibition of smoking in public places, the imposition of high taxes and the inclusion of large warnings on cigarette packages, all agreed with the active participation of the leaders of governments, including, in Uruguay, the direct participation of the President of the Republic. Unfortunately, the same does not occur in other countries of the region, such as Argentina, Peru, Guatemala, Honduras and Nicaragua.…”

Section: Smokingmentioning

confidence: 99%

Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome

López‐Jaramillo

Barbosa²,

Molina

et al. 2019

Journal of Hypertension

View full text Add to dashboard Cite

The prevalence of hypertension, type 2 diabetes mellitus (DM2) and the metabolic syndrome continues to increase in Latin America, while the rates of diagnosis, treatment and control of these disorders remain low. The frequency of the risk factors that constitute the metabolic syndrome and are associated with an increased risk of cardiovascular disease has not diminished since the publication of the previous consensus. This document discusses the socioeconomic, demographic, environmental and cultural characteristics of most associated Latin American countries and partially explains the lack of better results in improving clinical and public health actions that allow high morbidity and mortality rates caused by cardiovascular diseases and DM2 to be reduced through programs aligned with the socalled precision medicine, which should be predictive, preventive, personalized and participatory. The Consensus ratifies the diagnostic criteria expressed in the previous consensus to define hypertension and DM2 but, for the metabolic syndrome, and in the absence of evidence, the recommendation is to implement a cohort study that determines the abdominal perimeter value associated with hard outcomes, such as DM2 and CVD. Meanwhile, we recommend modifying the criterion to more than 94 cm in men and more than 84 cm in women according to WHO recommendations. We also recommend the carrying out of a study that identifies the situation of hypertension and DM2 in people of African ancestry who, in Latin America, exceed 75 million and whose epidemiology does not include solid studies. With respect to the proposed therapeutic targets, we recommended maintaining those defined in the previous consensus, but insisting that early pharmacological management of prediabetes with metformin should be introduced, as should the treatment of diabetic hypertensive patients with a combination therapy of two fixed-dose antihypertensive drugs and management with statins. To increase adherence, the use of different drugs combined in a single pill (polypill) is recommended. The simplification of the therapeutic regimen is accompanied by greater control of cardiovascular risk factors, both in primary and secondary prevention, and has been shown to be cost-effective. The consensus recommends the use of the currently available polypill combining an angiotensin-converting enzyme inhibitor, a statin and aspirin for secondary cardiovascular prevention and in patients with a high cardiovascular risk, such as hypertension patients with DM2.

show abstract

Section: Smokingmentioning

confidence: 99%

Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome

López‐Jaramillo

Barbosa²,

Molina

et al. 2019

Journal of Hypertension

View full text Add to dashboard Cite

show abstract

“…We continue to report findings from PDT studies elsewhere (e.g., Chin, et al in press; Dozier et al, 2006, 2009, 2014; Lando et al 2010; McIntosh, et al, 2008; Ossip-Klein, et al 2008; Ossip, et al; 2013, 2015; Prucha, et al 2015; Torres, et al 2011, 2014; Wipfli, et al 2008). The current paper will report on lessons learned from implementing this US-DR partnered research.…”

Section: Research Rationale/descriptionmentioning

confidence: 86%

“…More detail on training is provided elsewhere (Ossip-Klein, et al 2008; Ossip, et al 2015); lessons learned are presented here:…”

Section: Establishing An Infrastructure For Tobacco Cessation Researcmentioning

confidence: 99%

Lessons Learned from Twelve Years of Partnered Tobacco Cessation Research in the Dominican Republic

et al. 2016

Self Cite

View full text Add to dashboard Cite

Engaging partners for tobacco control within low and middle income countries (LMICs) at early stages of tobacco control presents both challenges and opportunities in the global effort to avert the one billion premature tobacco caused deaths projected for this century. The Dominican Republic (DR) is one such early stage country. The current paper reports on lessons learned from 12 years of partnered United States (US)-DR tobacco cessation research conducted through two NIH trials (Proyecto Doble T, PDT1 and 2). The projects began with a grassroots approach of working with interested communities to develop and test interventions for cessation and secondhand smoke reduction that could benefit the communities, while concurrently building local capacity and providing resources, data, and models of implementation that could be used to ripple upward to expand partnerships and tobacco intervention efforts nationally. Lessons learned are discussed in four key areas: partnering for research, logistical issues in setting up the research project, disseminating and national networking, and mentoring. Effectively addressing the global tobacco epidemic will require sustained focus on supporting LMIC infrastructures for tobacco control, drawing on lessons learned across partnered trials such as those reported here, to provide feasible and innovative approaches for addressing this modifiable public health crisis.

show abstract

“…Coordination of timing of reviews is critical to ensure that all are completed prior to study initiation. In addition, some IRBs may require approval by IRBs in the other participating countries prior to providing local approval, so it is critical for investigators to be aware of such local regulations and communicate documentation of approvals to each IRB within the required time frame [ 22 , 24 , 37 , 38 ].…”

Section: Methodsmentioning

confidence: 99%

“…In addition, in partner Dominican Republic communities, providing written consent for participation was culturally unacceptable as it raised concerns about contractual requirements. Thus, investigators worked with all IRBs to develop an acceptable verbal consent procedure with documentation of consent provided by data collectors [ 22 , 24 , 27 , 28 ]. Understanding IRB requirements of all participating sites is critical to successful global partnerships for research [ 37 ].…”

Section: Methodsmentioning

confidence: 99%

Development and Implementation of Culturally Tailored Offline Mobile Health Surveys

McIntosh¹,

Pérez-Ramos²,

Demment³

et al. 2016

JMIR Public Health Surveill

Self Cite

View full text Add to dashboard Cite

BackgroundIn low and middle income countries (LMICs), and other areas with low resources and unreliable access to the Internet, understanding the emerging best practices for the implementation of new mobile health (mHealth) technologies is needed for efficient and secure data management and for informing public health researchers. Innovations in mHealth technology can improve on previous methods, and dissemination of project development details and lessons learned during implementation are needed to provide lessons learned to stakeholders in both the United States and LMIC settings.ObjectiveThe aims of this paper are to share implementation strategies and lessons learned from the development and implementation stages of two survey research projects using offline mobile technology, and to inform and prepare public health researchers and practitioners to implement new mobile technologies in survey research projects in LMICs.MethodsIn 2015, two survey research projects were developed and piloted in Puerto Rico and pre-tested in Costa Rica to collect face-to-face data, get formative evaluation feedback, and to test the feasibility of an offline mobile data collection process. Fieldwork in each setting involved survey development, back translation with cultural tailoring, ethical review and approvals, data collector training, and piloting survey implementation on mobile tablets.ResultsCritical processes and workflows for survey research projects in low resource settings were identified and implemented. This included developing a secure mobile data platform tailored to each survey, establishing user accessibility, and training and eliciting feedback from data collectors and on-site LMIC project partners.ConclusionsFormative and process evaluation strategies are necessary and useful for the development and implementation of survey research projects using emerging mHealth technologies in LMICs and other low resource settings. Lessons learned include: (1) plan institutional review board (IRB) approvals in multiple countries carefully to allow for development, implementation, and feedback, (2) in addition to testing the content of survey instruments, allow time and consideration for testing the use of novel mHealth technology (hardware and software), (3) incorporate training for and feedback from project staff, LMIC partner staff, and research participants, and (4) change methods accordingly, including content, as mHealth technology usage influences and is influenced by the content and structure of the survey instrument. Lessons learned from early phases of LMIC research projects using emerging mHealth technologies are critical for informing subsequent research methods and study designs.

show abstract

Tobacco Cessation in Economically Disadvantaged Dominican Republic Communities: Who are the Ex-Users?

Cited by 3 publications

References 37 publications

Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome

Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome

Lessons Learned from Twelve Years of Partnered Tobacco Cessation Research in the Dominican Republic

Development and Implementation of Culturally Tailored Offline Mobile Health Surveys

Contact Info

Product

Resources

About